Canopy Growth Corporation Common Shares (CGC) is a publicly traded Healthcare sector company. As of May 21, 2026, CGC trades at $1.00 with a market cap of $415.34M and a P/E ratio of -0.55. CGC moved +4.57% today. Year to date, CGC is -13.45%; over the trailing twelve months it is -41.81%. Its 52-week range spans $0.77 to $5.80. Analyst consensus is buy with an average price target of $1.24. Rallies surfaces CGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Canopy Growth Jumps on U.S. Medical Marijuana Reclassification, Launches Tweed Summer Campaign: Canopy Growth shares jumped after the acting U.S. attorney general reclassified state-licensed medical marijuana from Schedule I to III, cutting compliance costs and unlocking federal tax benefits. In Canada, Canopy introduced a refreshed Tweed flower line with windowed packaging and a “There's a Tweed for That” summer campaign.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $415.34M |
| P/E Ratio | -0.55 |
| EPS | $-1.88 |
| Dividend Yield | 0.24% |
| 52-Week High | $5.80 |
| 52-Week Low | $0.77 |
| Volume | 21.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $278.39M |
| Net Income | $-326.58M |
| Gross Margin | 25.85% |
3 analysts cover CGC: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.24.